Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Care Continues To Draw Top Venture Dollars

This article was originally published in PharmAsia News

Executive Summary

Financial consulting firm ChinaVenture has published a Q1 2008 report on China's venture investment, which shows health care continues to be the hot favorite for investors. Capital injected in the industry reached $83.99 million in the quarter, 55.6 percent up over the same year-ago period. The proportion of funds channeled into health care by project number increased from 9.7 percent in Q1 2006 to 12.5 percent in Q4 2007; the percentage of total capital climbed from 10.4 percent to 22.3 percent over the same period. The number of health care programs invested in 2007 jumped to 32 from 19 the previous year; the $303 million attracted was 309.5 percent more than 2006. ChinaVenture believes that China's health reform policies and potential market are encouraging more funds into the industry, making it a key investment area. (Click here for more - Chinese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068376

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel